Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells by Seddiki, Nabila et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
BRIEF DEFINITIVE REPORT
JEM © The Rockefeller University Press  $8.00
Vol. 203, No. 7,  July 10, 2006  1693–1700  www.jem.org/cgi/doi/10.1084/jem.20060468
1693
CD4+ regulatory T (T reg) cells expressing the 
IL-2Rα chain (CD25) and the master regulator 
Foxp3 transcription factor play a vital role in 
controlling adaptive immune responses and 
maintaining self tolerance (1). Although the 
best evidence for their importance comes from 
mouse models, an increasing number of reports 
have outlined disturbances in T reg cell num-
bers and/or function in patients with a wide 
variety of autoimmune (2–8) and allergic dis-
eases (9, 10), in addition to the severe IPEX 
(immune dysregulation, polyendocrinopathy, 
enteropathy, and X-linked inheritance) syn-
drome in which Foxp3 itself is defective (11). 
Although some studies have demonstrated a 
  reduction in CD4+CD25+ T reg cell numbers 
in autoimmune conditions (2, 3, 8, 12), others 
have shown normal or even increased numbers 
of this same subset of T cells (5, 13–15). This 
may be due at least in part to the diffi   culty in 
accurately distinguishing T reg cells from 
CD25+ conventional T cells, particularly in 
  human peripheral blood where up to 20% of 
CD4+ T cells can express CD25 (16, 17).
Production of mAbs reactive with Foxp3 
has improved the specifi  city of T reg cell de-
tection over and above that provided by the 
combination of anti-CD4 and anti-CD25 (18). 
However, detection of Foxp3 requires fi  xation 
and permeabilization of the cells, so that the 
technique cannot be used to isolate viable T 
reg cell populations for functional studies and 
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Abnormalities in CD4+CD25+Foxp3+ regulatory T (T reg) cells have been implicated in 
susceptibility to allergic, autoimmune, and immunoinfl  ammatory conditions. However, 
phenotypic and functional assessment of human T reg cells has been hampered by diffi  culty 
in distinguishing between CD25-expressing activated and regulatory T cells. Here, we show 
that expression of CD127, the 𝗂 chain of the interleukin-7 receptor, allows an unambigu-
ous fl  ow cytometry–based distinction to be made between CD127lo T reg cells and CD127hi 
conventional T cells within the CD25+CD45RO+RA− effector/memory and CD45RA+RO− 
naive compartments in peripheral blood and lymph node. In healthy volunteers, peripheral 
blood CD25+CD127lo cells comprised 6.35 ± 0.26% of CD4+ T cells, of which 2.05 ± 0.14% 
expressed the naive subset marker CD45RA. Expression of FoxP3 protein and the CD127lo 
phenotype were highly correlated within the CD4+CD25+ population. Moreover, both 
effector/memory and naive CD25+CD127lo cells manifested suppressive activity in vitro, 
whereas CD25+CD127hi cells did not. Cell surface expression of CD127 therefore allows 
accurate estimation of T reg cell numbers and isolation of pure populations for in vitro 
studies and should contribute to our understanding of regulatory abnormalities in 
  immunopathic diseases.
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ex vivo expansion as a prelude to therapeutic administration. 
Recently, CD4+CD25+ conventional T cells that have 
down-regulated the costimulatory receptor CD27 after acti-
vation were shown to be distinguishable from T reg cells that 
continue to express CD27 (19). However, the vast majority 
of peripheral blood antigen-experienced CD25+ conven-
tional T cells also continue to express high levels of CD27 
(17), therefore limiting the applicability of CD27 as a T reg 
cell–specifi  c marker.
In this study, we show that surface expression of CD127, 
the α chain of the IL-7 receptor, in combination with CD25, 
the α chain of the IL-2 receptor, can distinguish between 
human regulatory and conventional CD4+ T cells in adult 
and cord blood, lymph nodes and thymus. Because IL-2 is 
critical for survival of regulatory T cells (20), we reasoned 
that they may not require IL-7, in contrast with many non-
regulatory T cell subsets that are IL-2 independent but re-
quire IL-7 (21). According to our fi  ndings, human T reg cells 
consistently express lower levels of CD127 than the majority 
of other CD4+ T cells. By virtue of its cell surface expression, 
CD127 provides a fl  exible alternative to the transcription fac-
tor FoxP3 for identifying and isolating human T reg cells for 
functional analysis.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
Expression of CD127 distinguishes between two 
populations of human CD25+CD4+ T cells
The capacity of CD127 expression to distinguish two pop-
ulations of CD25+CD4+ T cells in a variety of lymphoid 
tissues was tested by staining samples of normal adult blood, 
lymph node, cord blood, and thymus with mAbs to CD4, 
CD25, and CD127. Adult blood contained a population of 
CD25+CD127lo cells distinct from the majority population of 
CD127hi cells (Fig. 1 a). In addition to the CD25+CD127lo 
population, lymph nodes also contained a signifi  cant number 
of CD25−CD127lo T cells, which were prominent in blood 
from a minority of normal adults (unpublished data). In cord 
blood, staining with anti-CD127 revealed that the CD25+ 
population was not homogeneous, as previously claimed 
(22), but rather consisted of a mixture of CD25+CD127lo 
and CD25+CD127hi cells. In the thymus, where antigen-
  experienced cells expressing CD25 are absent, cells with the 
highest levels of CD25 retained intermediate expression of 
CD127 (Fig. 1 a).
Inverse correlation between expression of FoxP3 
and CD127 in CD4+CD25+ T cells
To measure expression of Foxp3 protein within the 
CD25+CD127lo population, cells from adult and cord blood, 
lymph node and thymus were costained with mAbs to Foxp3 
and CD127 (Fig. 1 b). In blood and lymph node, the popu-
lation of FoxP3+ cells was CD127lo and similar in size to 
that of CD25+CD127lo cells in Fig. 1 a. In contrast, the thy-
mic FoxP3+ population was considerably larger than the 
CD25+CD127lo population. In peripheral blood, 87% of 
CD4+CD127lo cells (gated as in Fig. 1 c, top left) fell within 
the CD25+Foxp3+ gate (Fig. 1 c, bottom left), and con-
versely, 84% of CD25+Foxp3+ cells were detected within the 
CD4+CD127lo gate (Fig. 1 c, right). In thymic CD4+CD8− 
T cells, however, 45% of Foxp3+ cells were CD25− (Fig. 1 d, 
bottom right), so that CD25+CD127lo cells comprised a sig-
nifi  cantly smaller population than Foxp3+ cells. Nonetheless, 
all thymic CD4+CD8−Foxp3+ cells were CD127lo. Thus the 
expression of CD25, CD127, and FoxP3 diff  ered between 
thymus and peripheral blood.
Figure 1.  Expression of CD127 and FoxP3 in adult blood, lymph 
node, cord blood, and thymus. (a) Plots are gated for CD4+CD8− 
T cells. CD25+CD127lo cells are boxed and the percentage of cells in 
the box is shown. In the lymph node sample, CD25−CD127lo cells are 
also boxed. (b) Plots are gated for CD4+CD8− T cells. FoxP3+CD127lo 
cells are boxed and the percentage of cells in the box is shown. 
(c) Correlation between FoxP3+CD25+ and CD25+CD127lo phenotypes 
in peripheral blood. Gating of CD4+ cells for each subset is shown, 
followed by the distribution of gated cells according to the reciprocal 
subset. (d) Correlation between FoxP3+ and CD25+CD127lo phenotypes 
in thymus.JEM VOL. 203, July 10, 2006  1695
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We (17) and others (23) have recently described a subset 
of naive CD4+CD45RA+CD25+ cells with regulatory activ-
ity in adult as well as cord blood. To test whether these cells 
also had a FoxP3+CD127lo phenotype, adult blood, lymph 
node, and cord blood cells were stained with mAbs to CD3, 
CD4, CD45RA, CD25, CD127, and FoxP3 (Fig. 2 a). 
CD3+CD4+ cells were separated into CD45RA− and 
CD45RA+ subsets, and the percentage of CD25+CD127lo 
cells within the Foxp3+ gate was calculated. In all tissues, 
>90% of total Foxp3+ cells were CD25+CD127lo, whereas 
the remaining cells were CD25intCD127hi. Moreover, the pro-
portion of CD127hi cells was similar within the CD45RA− 
and CD45RA+Foxp3+ subsets.
To determine the strength of the correlation between the 
percentage of cells within CD25+CD127lo and CD25+FoxP3+ 
populations, peripheral blood samples from nine healthy 
  volunteers were analyzed (Fig. 2 b). In both CD45RA− 
and CD45RA+ subsets, the cell numbers within the two 
gates were very similar, indicating that the number of 
CD25+CD127lo cells correlates strongly with the number of 
CD25+FoxP3+ cells in peripheral blood.
CD4+CD25+CD127lo cell numbers in peripheral blood 
of healthy volunteers
To defi  ne normal levels of circulating CD4+CD25+CD127lo 
cells, peripheral blood samples from a cohort of 43 healthy 
volunteers were examined (Fig. 3). The mean number 
(± SEM) of CD45RA−CD25+CD127lo cells as a percentage 
of CD4+ T cells was 4.29 ± 0.24, while the percentage of 
CD45RA+CD25+CD127lo cells was 2.05 ± 0.14, giving a 
total of 6.35 ± 0.26% of CD4+ T cells (Fig. 3 b). This was 
consistent with our fi  gure of 6.42 ± 0.50% of CD4+ T cells 
in murine blood (unpublished data), and contrasts with the 
conventional estimate of 1–2% in human peripheral blood 
(16). Moreover the ratio of eff  ector/memory to naive T reg 
cell (Fig. 3 a) was similar to the 2:1 ratio of eff  ector to naive 
Figure 2.  Correlation between expression of FoxP3 and CD127lo 
phenotype. (a) Leukocytes from adult blood, lymph node, and cord blood 
were gated into CD3+CD4+CD45RA+ and CD45RA− populations. FoxP3+ 
cells are boxed and the percentage of cells in the box is shown, together 
with expression of CD25 versus CD127 within the FoxP3+ gate. (b) Cor-
relation between the percentages of CD25+CD127lo and CD25+FoxP3+ 
cells within CD4+CD45RA+ and CD45RA− populations in nine peripheral 
blood samples from healthy volunteers.1696  CD25+CD127LO HUMAN T REG CELLS | Seddiki et al. 
T reg cells that we have previously determined for mice 
  (unpublished data). We (17) and others (23) have previously 
shown using CD4/CD25/CD45RA staining that the num-
ber of naive T reg cells in peripheral blood declines as a 
  function of age, suggestive of an eff  ect of thymic involution. 
This trend was confi   rmed with the new staining strategy 
(Fig. 3 b) and was only partially attributable to the well-
  described loss of CD45RA+ T cells with age. In contrast, the 
percentage of CD45RA− T reg cells was stable throughout 
life, as was the percentage of CD4+ T cells within peripheral 
blood leukocytes.
Measurement of mRNA for transcription factors 
in CD4+ T cell subsets sorted on the basis of CD127 
and CD25 expression
It has been reported that the level of FoxP3 protein does 
not always correlate with the mRNA level (22). We 
therefore measured the level of Foxp3 mRNA within 
sorted subsets of peripheral blood CD4+ T cells (Fig. 4 a). 
CD25+CD45RA−CD127lo cells (population 1) expressed 100-
fold more Foxp3 mRNA than CD25−CD45RA−CD127hi 
cells (population 4, Fig. 4 b). Intermediate levels of Foxp3 
mRNA were present in CD25+CD45RA−CD127hi cells 
(population 3) and CD25−CD45RA−CD127lo cells (popu-
lation 2), as previously shown for CD25intCD45RA− cells 
(17). Population 2 expressed the highest levels of mRNA for 
T-bet, a master regulator of Th1 eff  ector function, whereas 
GATA3 (a master regulator of Th2 function) was expressed 
equally by all populations (Fig. 4 c). These results confi  rm 
that population 2 contains CD127lo eff  ector cells. Within the 
CD45RA+ fraction, CD25+CD127lo cells expressed 100-
fold more Foxp3 than naive CD25−CD127hi cells (Fig. 4 b), 
as previously shown for CD25+CD45RA+ cells (17).
In cord blood, CD25+CD127lo cells expressed 500-fold 
more Foxp3 mRNA than the corresponding naive CD4+CD25− 
cells (Fig. 4 b, right), consistent with our previously published 
results (17). The CD25intCD127hi population (population 8) of 
antigen-experienced T cells expressed an intermediate level of 
Foxp3, as demonstrated for the corresponding adult population 
(population 3, Fig. 4 b).
In vitro suppression by subsets sorted on the basis 
of CD127 staining
Adult blood CD4+ T cells divided into CD45RA+ and 
CD45RA− subsets were sorted according to the gates illus-
trated in Fig. 5 a (left). Autologous sorted CD45RA+CD25− 
cells (population 5) were used as responder cells in cocultures 
to measure suppressive activity. Assays using either thymidine 
(Fig. 5 b) or CFSE (not depicted) as the indicator of cell pro-
liferation showed that only the CD25+CD127lo T cells within 
each CD45 subset (populations 1 and 3, Fig. 5 b) mediated 
in vitro suppression. CD45RA+ T reg cells were as potent 
as their CD45RA− counterparts, in agreement with recently 
published studies (17, 23). For cord blood assays, CD45 
  isoform expression was not used to subdivide cells, as the vast 
majority of cord blood cells express CD45RA to some 
extent. CD25+CD127lo and CD25+CD127hi subsets sorted 
according to the gates in Fig. 3 a (right) were cocultured with 
autologous responder CD4+CD25−CD127hi cells (popula-
tion 8). Once again, both thymidine (Fig. 5 b) and CFSE 
  assays (not depicted) indicated that the suppressive activity of 
Figure 3.  Percentages of CD4+CD25+CD127lo cells in peripheral 
blood from 43 healthy volunteers. (a) Gating strategy for CD4+ cells 
subdivided into CD45RA− and CD45RA+ subpopulations. Boxes indicate 
the placement of the analysis gates for each cell population. (b) CD45RA− 
and CD45RA+CD25+CD127lo cells, expressed as a percentage of total 
CD4+ T cells. Total T reg cell percentages were derived by adding together 
the values for CD45RA− and CD45RA+ T reg cell subsets. Horizontal bars 
represent the group means. (c) Relationship between various CD4+ T cell 
subpopulations and age.JEM VOL. 203, July 10, 2006  1697
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CD4+CD25+ cells was confi   ned to the CD127lo subset 
  (population 6, Fig. 5 b).
Previous reports have indicated that CD25bright but not 
CD25int cells have suppressive activity (16). However, in 
those studies the majority of cells in the CD25int gate would 
have been CD45RA−CD127hi conventional T cells (popula-
tion 2, Fig. 5, a and b), compromising the effi   ciency of 
suppression in the assay. To compare the suppressive activ-
ity of CD45RA−CD127lo cells expressing diff  erent levels of 
CD25, adult blood CD4+ T cells divided into CD45RA+ 
Figure 4.  Quantitative analysis of Foxp3 mRNA expression in 
sorted populations of CD4+ T cells. (a) Sorting strategy for isolation of 
subsets of CD4+ T cells from adult and cord blood. Dot plots are gated for 
lymphocytes expressing CD4, together with CD45RA in the case of adult 
blood. Numbered boxes indicate the placement of the fl  ow sorting gates 
for each cell population. (b) RT qPCR for Foxp3 was performed in dupli-
cate using RNA prepared from sorted cell populations. Sorted CD45RA− 
cells from four donors were compared, whereas suffi  cient CD45RA+ cells 
were available from only two donors. (c) RT qPCR for T-bet and GATA3 
using RNA prepared from sorted cell populations from two adult donors.1698  CD25+CD127LO HUMAN T REG CELLS | Seddiki et al. 
Figure 5.  Suppression of in vitro proliferation by T reg cells from 
adult and cord blood. (a) Sorting strategy for isolation of subsets of 
CD4+ T cells. Dot plots are gated for lymphocytes expressing CD4, 
  together with CD45RA in the case of adult blood. Numbered boxes indi-
cate the placement of the fl  ow sorting gates for each cell population. 
(b) Suppression by fl  ow sorted populations (nos. 1–5) from adult blood 
and populations (nos. 6–8) from cord blood. Responder cells were sorted 
autologous CD4+CD45RA+CD25− cells (population 5) for adult blood and 
autologous CD4+CD25− cells (population 8) for cord blood. Ratios of 
suppressor to responder cells are shown above the fi  gure. Bars represent 
the mean ± SEM of three to four replicate cultures. Assays of adult blood 
are representative of two independent experiments and the cord blood 
data are derived from a single experiment. (c) Strategy for isolation of 
subsets of CD4+CD127lo T cells from adult blood, sorted on the basis of 
CD25 expression. (d) Suppression and cytokine production by fl  ow sorted 
populations (nos. 9–14) from adult blood. Responder cells were sorted 
autologous CD4+CD45RA+CD25− cells (population 14). Limit of detection 
in the cytokine assays is indicated by the dotted line. nd, not detected. 
(f) Transwell cultures of fl  ow sorted populations (nos. 9, 13–14, and nil) 
at a 1:1 ratio.JEM VOL. 203, July 10, 2006  1699
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and CD45RA− subsets were sorted according to the gates 
  illustrated in Fig. 5 c. All three CD45RA−CD25+CD127lo 
populations (populations 9–11) manifested suppressive activ-
ity (Fig. 5 d, bottom left), consistent with their high level of 
FoxP3 expression (Fig. 2). In addition, all three populations 
suppressed IFNγ production by responder cells, and popula-
tions 10 and 11 secreted a small amount of IL-10. No secre-
tion of IL-4 or IL-5 was detected in any cultures (unpublished 
data). Interestingly, CD45RA−CD25−CD127lo cells (popu-
lation 12) showed some suppression of proliferation and 
IFNγ production, and secreted a detectable level of IL-10, 
although they do not express FoxP3 protein (Figs. 1 and 2).
To test whether cell surface interaction between T reg 
cell and responder cells was required for suppression by 
CD25+CD127lo cells, transwell cultures were performed 
(Fig. 5 e). No suppression was seen when cell–cell con-
tact between suppressor and responder cells was prevented, 
ruling out a role for soluble factors such as IL-10 in sup-
pression by CD25+CD127lo cells. Indeed, in the transwell 
cultures, the proliferation of responder cells was augmented 
when   compared with the control cultures lacking suppressor 
cells (Fig. 5 e).
Collectively, these results indicate that suppressive activ-
ity was restricted to CD25+CD127lo cells in both cord and 
adult blood. In contrast, markers such as HLA-DR, which 
split CD4+CD25+ T cells into two populations, distinguish 
T reg cell subsets with diff  erent spectra of activity in   vitro 
(24). A small proportion (<10%) of CD25+FoxP3+ cells 
  retained high expression of CD127 (Fig. 2). Whether 
these cells have suppressive function remains unknown be-
cause they cannot currently be purifi  ed for testing in vitro. 
  Nonetheless the population of CD25+CD127hi cells as a 
whole does not manifest suppressive activity in standard in 
vitro   assays (Fig. 5). These data are therefore consistent with 
several recent studies indicating that expression of FoxP3 
does not always confer obligatory suppressive function on 
human T cells (25, 26).
Conclusions
We have shown that human peripheral CD4+CD25+ 
T reg cells can be accurately identifi  ed and purifi  ed us-
ing surface expression of CD127, as an alternative to the 
transcription factor FoxP3. Murine T reg cells have also 
been reported to express low levels of CD127, but the 
decrease in its expression is insuffi   cient to allow accurate 
fl  ow-based separation from other CD4+ T cells (27, 28). 
In a recent publication, diff   erential CD127 expression 
was demonstrated for CD4+CD25+ T reg cell and naive 
CD4+CD25− T cells in human fetal lymph node sam-
ples (29). However, this report is, to our knowledge, the 
fi   rst demonstration that antigen-experienced CD45RA− 
(CD45RO+) conventional CD4+ T cells, the major con-
taminant of CD25+CD4+ T reg cells as normally identifi  ed, 
can be excluded from both neonatal and adult blood and 
lymph node T reg cell populations in a fl  ow-based strategy 
using anti-CD127 mAbs.
MATERIALS AND METHODS
Samples. Peripheral blood was obtained from healthy adult donors 
  (Centenary Institute and Rush University Medical Center). Buff  y coats 
were obtained from the Australian Red Cross Blood Service. Cord blood 
samples from Nepean Hospital, Australia, were obtained from umbilical 
cord veins immediately after delivery of the placenta. The neonates were 
full-term and had no hematologic abnormalities or infectious complications. 
Normal   thymus specimens were from children aged 1–7 mo undergoing 
corrective cardiac surgery at the Children’s Hospital (Australia). Lymph 
nodes were obtained from patients undergoing colectomy for incontinence. 
The study was performed with the approval of the Central and Western 
Sydney Area Health Services Ethics Committees, the Royal Alexandra 
Hospital for Children Ethics Committee, and the Rush Institutional   Review 
Board. Informed consent was provided in accordance with the declaration 
of Helsinki.
Mononuclear cell preparations. Peripheral blood, buff  y coat, cord blood, 
thymus, and lymph node mononuclear cells were prepared as described 
  previously (17).
Antibodies and fl  ow  cytometry. Anti-CD4, anti-CD25, and anti-
CD45RO mAbs (clones OKT4, 7GB6 and UCHTL-1, respectively) were 
labeled with Alexa488 (Invitrogen) and FITC (Sigma-Aldrich) by standard 
protocols. Additional monoclonal antibodies used in this study were as 
follows: anti-CD3, -CD4, -CD8, -CD45RA, -CD45RO (BD Biosciences); 
-CD25 (BD Biosciences); -CD127 (Immunotech); and -Foxp3 (eBioscience). 
Abs were conjugated with biotin, Alexa488, FITC, PE, PerCpCy5.5, Pa  cifi  c 
blue, PECy7, or PECy5.5. Biotin conjugates were developed with streptavidin 
conjugated with Alexa594 (Invitrogen) or PerCP (BD Biosciences).
Staining for fl  ow cytometry was performed as previously described (17). 
A total of 105 events, gated for lymphocytes on the basis of forward and side 
scatter profi  les, were collected using a FACSCalibur, FACSVantage, FAC-
SAria, or LSRII (Becton Dickinson). Analysis was performed using the FlowJo 
program (Treestar). Sorting was performed on a FACSVantage or FACSAria 
cell sorter.
Real-time qPCR. Real-time qPCR for Foxp3, T-bet, and GATA-3 was 
performed as described previously (17). Relative expression was determined 
by normalization to β-actin.
In vitro suppression assays. In vitro suppression assays were performed as 
previously described (17). The number of putative suppressor cells added 
to each well was either 2 × 104, 0.5 × 104, 2 × 103, or zero, giving fi  nal 
suppressor to responder ratios of 1:1, 0.25:1, 0.1:1, or 0:1, respectively. After 
72 h of culture, 100 μl of supernatant was removed from each well for cyto-
kine assays, before pulsing with tritiated thymidine for 16 h before harvest-
ing. CFSE assays were performed in parallel using labeled responder cells 
harvested after 72 h of culture. Cytokines (IFN-γ, IL-4, IL- 5, IL-10) 
were measured using OptEIA kits (BD Biosciences) according to the manu-
facturer’s instructions. Transwell assays were performed in 24-well plates as 
  described previously (16).
Statistical analysis. Statistical analyses were performed using Prism 4.0 
(GraphicPad) or Cricket Graph III (Computer Associates International) 
  software. Parametric statistical analysis (mean and SEM, linear and exponen-
tial regression) was performed using standard methods. Signifi  cance of cor-
relation coeffi   cients (nonparametric) was calculated using the Spearman test. 
For all tests, p-values <0.05 were considered signifi  cant.
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